MiR-155 Inhibits Malignant Biological Behavior of Human Liver Cancer Cells by Regulating SRPK1
Although the treatment of liver cancer has made great progress, the mechanism of its occurrence is not completely clear. miR-155 plays an important regulatory role in tumorigenesis and development, including survival, proliferation, migration and invasion. However, the role and regulatory mechanism...
Main Authors: | Qi Wang, Guo-tai Wang, Wei-hong Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-04-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/1533033820957021 |
Similar Items
-
The role of miR-155 in urologic malignancies
by: Maolei Shen, et al.
Published: (2024-05-01) -
Therapeutic inhibition of miR-155 attenuates liver fibrosis via STAT3 signaling
by: Shashi Bala, et al.
Published: (2023-09-01) -
miR-150 and SRPK1 regulate AKT3 expression to participate in LPS-induced inflammatory response
by: Yanfen Yao, et al.
Published: (2021-05-01) -
MiR-659-3p inhibits osteosarcoma progression and metastasis by inhibiting cell proliferation and invasion via targeting SRPK1
by: Yubao Gong, et al.
Published: (2022-08-01) -
LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p
by: Han X, et al.
Published: (2021-06-01)